Annual Accounts Payable
$7.05 M
+$3.56 M+102.12%
December 31, 2023
Summary
- As of February 7, 2025, XTNT annual accounts payable is $7.05 million, with the most recent change of +$3.56 million (+102.12%) on December 31, 2023.
- During the last 3 years, XTNT annual accounts payable has risen by +$4.11 million (+139.36%).
- XTNT annual accounts payable is now -32.64% below its all-time high of $10.47 million, reached on December 31, 2016.
Performance
XTNT Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$8.30 M
+$1.42 M+20.70%
September 30, 2024
Summary
- As of February 7, 2025, XTNT quarterly accounts payable is $8.30 million, with the most recent change of +$1.42 million (+20.70%) on September 30, 2024.
- Over the past year, XTNT quarterly accounts payable has increased by +$2.94 million (+54.87%).
- XTNT quarterly accounts payable is now -35.62% below its all-time high of $12.89 million, reached on September 30, 2016.
Performance
XTNT Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
XTNT Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +102.1% | +54.9% |
| 3 y3 years | +139.4% | +252.4% |
| 5 y5 years | +9.1% | +269.0% |
XTNT Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +169.8% | at high | +217.3% |
| 5 y | 5-year | at high | +222.4% | at high | +279.3% |
| alltime | all time | -32.6% | >+9999.0% | -35.6% | >+9999.0% |
Xtant Medical Holdings Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $8.30 M(+20.7%) |
| Jun 2024 | - | $6.88 M(-6.8%) |
| Mar 2024 | - | $7.38 M(+4.6%) |
| Dec 2023 | $7.05 M(+102.1%) | $7.05 M(+31.7%) |
| Sep 2023 | - | $5.36 M(+20.6%) |
| Jun 2023 | - | $4.44 M(+29.9%) |
| Mar 2023 | - | $3.42 M(-2.0%) |
| Dec 2022 | $3.49 M(+33.5%) | $3.49 M(-7.6%) |
| Sep 2022 | - | $3.78 M(+24.2%) |
| Jun 2022 | - | $3.04 M(+9.7%) |
| Mar 2022 | - | $2.77 M(+6.1%) |
| Dec 2021 | $2.62 M(-11.3%) | $2.62 M(+11.0%) |
| Sep 2021 | - | $2.35 M(-10.8%) |
| Jun 2021 | - | $2.64 M(+6.0%) |
| Mar 2021 | - | $2.49 M(-15.5%) |
| Dec 2020 | $2.95 M(+34.7%) | $2.95 M(+4.7%) |
| Sep 2020 | - | $2.81 M(-8.4%) |
| Jun 2020 | - | $3.07 M(-14.9%) |
| Mar 2020 | - | $3.61 M(+64.9%) |
| Dec 2019 | $2.19 M(-66.2%) | $2.19 M(-2.7%) |
| Sep 2019 | - | $2.25 M(-29.6%) |
| Jun 2019 | - | $3.19 M(-47.1%) |
| Mar 2019 | - | $6.04 M(-6.6%) |
| Dec 2018 | $6.46 M(-30.6%) | $6.46 M(+9.2%) |
| Sep 2018 | - | $5.92 M(-21.4%) |
| Jun 2018 | - | $7.53 M(-0.0%) |
| Mar 2018 | - | $7.53 M(-19.2%) |
| Dec 2017 | $9.32 M(-11.0%) | $9.32 M(+26.7%) |
| Sep 2017 | - | $7.35 M(-13.0%) |
| Jun 2017 | - | $8.45 M(-5.1%) |
| Mar 2017 | - | $8.90 M(-15.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $10.47 M(+11.6%) | $10.47 M(-18.8%) |
| Sep 2016 | - | $12.89 M(+0.8%) |
| Jun 2016 | - | $12.79 M(+3.2%) |
| Mar 2016 | - | $12.39 M(+32.0%) |
| Dec 2015 | $9.39 M(+142.1%) | $9.39 M(+25.4%) |
| Sep 2015 | - | $7.49 M(+63.5%) |
| Jun 2015 | - | $4.58 M(+3.7%) |
| Mar 2015 | - | $4.41 M(+13.8%) |
| Dec 2014 | $3.88 M(+40.1%) | $3.88 M(-0.4%) |
| Sep 2014 | - | $3.89 M(-8.4%) |
| Jun 2014 | - | $4.25 M(-0.0%) |
| Mar 2014 | - | $4.25 M(+53.5%) |
| Dec 2013 | $2.77 M(-30.8%) | $2.77 M(-14.2%) |
| Sep 2013 | - | $3.23 M(-24.0%) |
| Jun 2013 | - | $4.25 M(+6.6%) |
| Mar 2013 | - | $3.98 M(-0.4%) |
| Dec 2012 | $4.00 M(+50.6%) | $4.00 M(-1.4%) |
| Sep 2012 | - | $4.06 M(+12.5%) |
| Jun 2012 | - | $3.61 M(-6.7%) |
| Mar 2012 | - | $3.86 M(+45.6%) |
| Dec 2011 | $2.65 M(+17.4%) | $2.65 M(+20.1%) |
| Sep 2011 | - | $2.21 M(-10.9%) |
| Jun 2011 | - | $2.48 M(-23.2%) |
| Mar 2011 | - | $3.23 M(+42.9%) |
| Dec 2010 | $2.26 M(+61.0%) | $2.26 M(+29.2%) |
| Sep 2010 | - | $1.75 M(+15.0%) |
| Jun 2010 | - | $1.52 M(>+9900.0%) |
| Mar 2010 | - | $13.00 K(-99.1%) |
| Dec 2009 | $1.40 M(+2626.2%) | $1.40 M(>+9900.0%) |
| Sep 2009 | - | $3900.00(-92.4%) |
| Dec 2008 | $51.50 K | $51.50 K |
FAQ
- What is Xtant Medical Holdings annual accounts payable?
- What is the all time high annual accounts payable for Xtant Medical Holdings?
- What is Xtant Medical Holdings annual accounts payable year-on-year change?
- What is Xtant Medical Holdings quarterly accounts payable?
- What is the all time high quarterly accounts payable for Xtant Medical Holdings?
- What is Xtant Medical Holdings quarterly accounts payable year-on-year change?
What is Xtant Medical Holdings annual accounts payable?
The current annual accounts payable of XTNT is $7.05 M
What is the all time high annual accounts payable for Xtant Medical Holdings?
Xtant Medical Holdings all-time high annual accounts payable is $10.47 M
What is Xtant Medical Holdings annual accounts payable year-on-year change?
Over the past year, XTNT annual accounts payable has changed by +$3.56 M (+102.12%)
What is Xtant Medical Holdings quarterly accounts payable?
The current quarterly accounts payable of XTNT is $8.30 M
What is the all time high quarterly accounts payable for Xtant Medical Holdings?
Xtant Medical Holdings all-time high quarterly accounts payable is $12.89 M
What is Xtant Medical Holdings quarterly accounts payable year-on-year change?
Over the past year, XTNT quarterly accounts payable has changed by +$2.94 M (+54.87%)